2Chen JJ,Chang CS,Tai Di,et al. Role of Helicobacter Pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci, 1994,39:1565 ～ 1568
3Wu CS, Lin CY, Liaw YF. Helicobacter Pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc, 1995,42:427
4郑芝田,主编.消化性溃疡病.第1版.北京:人民卫生出版社,1998.782-785
5冉其荣,王冬.肝硬化门静脉高压性胃病的临床观察[J]中华肝脏病杂志,2000(04).
6Decaux G.Difference is solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985[].Journal of Laboratory and Clinical Medicine.2001
7Gadano A,Moreau R,Pessione F,et al.Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis[].Journal of Hepatology.2000
8Gines P,Jimenez W.Aquaretic agent: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
9Gines P,Jimenez W.Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
10Bosch-Marce M,Jimenez W,Angeli P,et al.Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention[].Gastroenterology.1995
